Literature DB >> 10867200

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

M M Breteler1.   

Abstract

Vascular disease and Alzheimer's disease are both common disorders, in particular among elderly subjects. Therefore, it can be expected that the joint occurrence of these two disorders is not a rare phenomenon. In recent years, evidence is increasing that the two may be more closely linked than just by chance. Epidemiological studies have suggested that risk factors for vascular disease and stroke are associated with cognitive impairment and Alzheimer's disease, and that the presence of cerebrovascular disease intensifies the presence and severity of the clinical symptoms of Alzheimer's disease. In this paper, current knowledge on the relation between vascular risk factors and risk indicators and Alzheimer's disease will be reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 10867200     DOI: 10.1016/s0197-4580(99)00110-4

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  185 in total

1.  Cerebral blood flow and neuropsychological functioning in elderly vascular disease patients.

Authors:  David J Moser; Laura L Boles Ponto; Ivy N Miller; Susan K Schultz; Yusuf Menda; Stephan Arndt; Peggy C Nopoulos
Journal:  J Clin Exp Neuropsychol       Date:  2011-12-13       Impact factor: 2.475

2.  Cognitive function in the community setting: the neighbourhood as a source of 'cognitive reserve'?

Authors:  Philippa J Clarke; Jennifer A Ailshire; James S House; Jeffrey D Morenoff; Katherine King; Robert Melendez; Kenneth M Langa
Journal:  J Epidemiol Community Health       Date:  2011-04-22       Impact factor: 3.710

Review 3.  Cardiovascular risk factors and Alzheimer's disease.

Authors:  José A Luchsinger; Richard Mayeux
Journal:  Curr Atheroscler Rep       Date:  2004-07       Impact factor: 5.113

4.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

5.  Cerebrovascular lesions induce transient β-amyloid deposition.

Authors:  Monica Garcia-Alloza; Julia Gregory; Kishore V Kuchibhotla; Sara Fine; Ying Wei; Cenk Ayata; Matthew P Frosch; Steven M Greenberg; Brian J Bacskai
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

Review 6.  Perimenopause and cognition.

Authors:  Gail A Greendale; Carol A Derby; Pauline M Maki
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

7.  Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome.

Authors:  Shinobu Kitazume; Akiomi Yoshihisa; Takayoshi Yamaki; Masayoshi Oikawa; Yuriko Tachida; Kazuko Ogawa; Rie Imamaki; Yoshiaki Hagiwara; Noriaki Kinoshita; Yasuchika Takeishi; Katsutoshi Furukawa; Naoki Tomita; Hiroyuki Arai; Nobuhisa Iwata; Takaomi Saido; Naomasa Yamamoto; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

8.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

9.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

10.  Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.

Authors:  Byung Hee Han; Meng-Liang Zhou; Fadi Abousaleh; Robert P Brendza; Hans H Dietrich; Jessica Koenigsknecht-Talboo; John R Cirrito; Eric Milner; David M Holtzman; Gregory J Zipfel
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.